NCT00644007View on ClinicalTrials.gov

Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction and Hypertension

PHASE3CompletedINTERVENTIONAL

Enrollment

109

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

December 31, 2008

Conditions

Erectile Dysfunction

Interventions

DRUG

Placebo

Placebo as a substitute of SK3530 100mg

DRUG

SK3530

SK3530 100 mg

Trial Locations (1)

135-847

SK Chemicals Co., Ltd, Seoul

All Listed Sponsors

lead

SK Chemicals Co., Ltd.

INDUSTRY

NCT00644007 - Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction and Hypertension | Biotech Hunter | Biotech Hunter